Nine Chapters Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-15,800
Closed -$440K 445
2015
Q3
$440K Sell
15,800
-3,600
-19% -$130K 0.04% 609
2015
Q2
$801K Sell
19,400
-17,000
-47% -$623K 0.07% 405
2015
Q1
$1.1M Buy
+36,400
New +$944K 0.09% 350
2014
Q4
Sell
-22,100
Closed -$440K 1132
2014
Q3
$440K Sell
22,100
-28,300
-56% -$596K 0.04% 566
2014
Q2
$1.15M Buy
+50,400
New +$897K 0.09% 301

Other funds holding RGEN

Nine Chapters Capital Management's RGEN Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Repligen (RGEN) in Q4 2015, closing a stake of 15,800 shares — an estimated $440K sold.

Nine Chapters Capital Management first reported a position in RGEN in Q2 2014 and held it in 5 quarters. The position peaked at $1.15M in Q2 2014. 176 funds tracked by Wall St. Rank hold RGEN as of Q4 2015.

  • Nine Chapters Capital Management reported no remaining Repligen position as of Q4 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 15,800 Repligen shares in Q4 2015, an estimated $440K.
  • Nine Chapters Capital Management first reported a position in Repligen in Q2 2014 and held it in 5 quarters.
  • Nine Chapters Capital Management's Repligen position peaked at $1.15M in Q2 2014.
  • 176 funds tracked by Wall St. Rank held Repligen as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.